Xu, J., Shi, S., Wei, M., Li, J., Du, N., Han, B., Wang, J., Yu, X. (2026). SHR-A2102, a Nectin-4 targeted antibody-drug conjugate, combined with HRS-4642 in previously treated pancreatic ductal adenocarcinoma harboring KRAS G12D mutation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4191